1K17 - Header Asymmetric Unit

HEADER HYDROLASE 24-SEP-01 1K17

TITLE ALIPHATIC AMIDASE (EC 3.5.1.4)

COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALIPHATIC AMIDASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 20-290; COMPND 5 EC: 3.5.1.4

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_COMMON: BACTERIA; SOURCE 4 STRAIN: 8602

KEYWDS HYDROLASE, NITRILASE, AMIDASE, CATALYTIC TRIAD, COMPARATIVE KEYWDS 2 MODELLING, NITFHIT

EXPDTA THEORETICAL MODEL

AUTHOR C.NOVO,S.FARNAUD,R.TATA,A.CLEMENTE,P.R.BROWN

REVDAT 2 17-MAY-05 1K17 1 JRNL REVDAT 1 10-OCT-01 1K17 0

JRNL AUTH C.NOVO,S.FARNAUD,R.TATA,A.CLEMENTE,P.R.BROWN JRNL TITL SUPPORT FOR A THREE-DIMENSIONAL STRUCTURE JRNL TITL 2 PREDICTING A CYS-GLU-LYS CATALYTIC TRIAD FOR JRNL TITL 3 PSEUDOMONAS AERUGINOSA AMIDASE COMES FROM JRNL TITL 4 SITE-DIRECTED MUTAGENESIS AND MUTATIONS ALTERING JRNL TITL 5 SUBSTRATE SPECIFICITY JRNL REF BIOCHEM.J. V. 365 731 2002 JRNL REFN ASTM BIJOAK UK ISSN 0264-6021

REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.C.PEITSCH REMARK 1 TITL PROTEIN MODELING BY EMAIL REMARK 1 REF BIO/TECHNOLOGY V. 13 658 1995 REMARK 1 REFN ASTM BTCHDA US ISSN 0733-222X REMARK 1 REFERENCE 2 REMARK 1 AUTH M.C.PEITSCH REMARK 1 TITL PROMOD AND SWISS-MODEL: INTERNET-BASED TOOLS FOR REMARK 1 TITL 2 AUTOMATED COMPARATIVE PROTEIN MODELLING. REMARK 1 REF BIOCHEM. SOC. TRANS. V. 24 274 1996 REMARK 1 REFN ASTM BCSTB5 UK ISSN 0300-5127 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.C.PEITSCH,N.GUEX REMARK 1 TITL LARGE-SCALE COMPARATIVE PROTEIN MODELLING REMARK 1 REF PROTEOME RESEARCH: NEW V. 19 177 1997 REMARK 1 REF 2 FRONTIERS IN FUNCTIONAL REMARK 1 REF 3 GENOMICS REMARK 1 REFN US ISSN 3-540-62775-8 REMARK 1 REFERENCE 4 REMARK 1 AUTH M.C.PEITSCH,N.GUEX REMARK 1 TITL SWISS-MODEL AND THE SWISS-PDBVIEWER: AN REMARK 1 TITL 2 ENVIRONMENT FOR COMPARATIVE PROTEIN MODELLING REMARK 1 REF ELECTROPHORESIS V. 18 2714 1997 REMARK 1 REFN GE ISSN 0173-0835 REMARK 1 REFERENCE 5 REMARK 1 AUTH T.YONEDA,H.KOMOOKA,H.UMEYAMA REMARK 1 TITL A COMPUTER MODELING STUDY OF THE INTERACTION REMARK 1 TITL 2 BETWEEN TISSU FACTOR PATHWAY INHIBITOR AND BLOOD REMARK 1 TITL 3 COAGULATION FACTOR XA. REMARK 1 REF J.PROTEIN CHEM. V. 16 597 1997 REMARK 1 REFN ASTM JPCHD2 UK ISSN 0277-8033 REMARK 1 REFERENCE 6 REMARK 1 AUTH K.OGATA,H.UMEYAMA REMARK 1 TITL PREDICTION OF PROTEIN SIDE-CHAIN CONFORMATIONS BY REMARK 1 TITL 2 PRINCIPAL COMPONENT ANALYSIS FOR FIXED MAIN-CHAIN REMARK 1 TITL 3 ATOMS. REMARK 1 REF PROTEIN ENG. V. 10 353 1997 REMARK 1 REFN ASTM PRENE9 UK ISSN 0269-2139 REMARK 1 REFERENCE 7 REMARK 1 AUTH K.OGATA,H.UMEYAMA REMARK 1 TITL THE ROLE PLAYED BY ENVIRONMENTAL RESIDUES ON REMARK 1 TITL 2 SIDECHAIN TORSIONAL ANGLES WITHIN HOMOLOGOUS REMARK 1 TITL 3 FAMILIES OF PROTEINS: A NEW METHOD OF SIDECHAIN REMARK 1 TITL 4 MODELING. REMARK 1 REF PROTEINS: V. 31 355 1998 REMARK 1 REF 2 STRUCT.,FUNCT.,GENET. REMARK 1 REFN ASTM PSFGEY US ISSN 0887-3585 REMARK 1 REFERENCE 8 REMARK 1 AUTH H.C.PACE,S.C.HODAWADEKAR,A.DRAGANESCU,J.HUANG, REMARK 1 AUTH 2 P.BIEGANOWSKI,Y.PEKARSKY,C.M.CROCE,C.BRENNER REMARK 1 TITL CRYSTAL STRUCTURE OF THE WORM NITFHIT ROSETTA REMARK 1 TITL 2 STONE PROTEIN REVEALS A NIT TETRAMER BINDING TWO REMARK 1 TITL 3 FHIT DIMERS. REMARK 1 REF CURR. BIOL. V. 10 907 2000 REMARK 1 REFN ASTM CUBLE2 UK ISSN 0960-9822

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 1K17 COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-SEP-2001. REMARK 100 THE RCSB ID CODE IS RCSB014431.

REMARK 220 REMARK 220 THIS MODEL IS BASED UPON THE COORDINATES OF: REMARK 220 PDB ENTRY 1EMS REMARK 220 REMARK 220 MODELLING METHOD. REMARK 220 PROGRAM : PROMODII REMARK 220 AUTHORS : N.GUEX,M.C.PEITSCH REMARK 220 REMARK 220 ENERGY MINIMSATION. REMARK 220 PROGRAM : GROMOS96 REMARK 220 AUTHORS : VAN GUNSTEREN REMARK 220 PARAMETER : IFP43B1 REMARK 220 TOPOLOGY FILE : MTB43B1 REMARK 220 METHOD 1 : STEEPEST DESCENT REMARK 220 CYCLES 1 : 200 REMARK 220 CONSTRAINTS 1 : 25 / C-FACTORS REMARK 220 METHOD 2 : CONJUGATE GRADIENT REMARK 220 CYCLES 2 : 300 REMARK 220 CONSTRAINTS 2 : 2500 / C-FACTORS REMARK 220 REMARK 220 STRUCTURE SOLUTION. REMARK 220 REMARK 220 PROGRAM : FAMS REMARK 220 AUTHOR : YONEDA,KOMOOKA,UMEYAMA,OGATA REMARK 220 REMARK 220 PROGRAM : SWISSMODEL 3.5 REMARK 220 AUTHOR : PEITSCH,GUEX REMARK 220 REMARK 220 DATA ANALYSIS. REMARK 220 REMARK 220 PROGRAM : SWISSPDB VIEWER 3.7B2 REMARK 220 AUTHOR : GUEX,PEITSCH REMARK 220 REMARK 220 PROGRAM : PROCHECK 3.4 REMARK 220 AUTHOR : LASKOWSKI,MCARTHUR,MOSS,THORNTON REMARK 220 REMARK 220 PROGRAM : MAPS 3.1 REMARK 220 AUTHOR : LU REMARK 220 REMARK 220 PROGRAM : TOPS REMARK 220 AUTHOR : FLORES,MOSS,THORNTON

REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 79 -52.56 81.70 REMARK 500 ASP A 123 -138.86 19.99 REMARK 500 CYS A 166 -114.28 53.45

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1EMS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE C. ELEGANS NITFHIT PROTEIN

REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE 40 IS IN CONFLICT IN SWISS-PROT ENTRY P11436. REMARK 999 IT CAN BE EITHER ASP OR GLU.

DBREF 1K17 A 20 290 UNP P11436 ALAM_PSEAE 20 290

SEQADV 1K17 ASP A 40 UNP P11436 GLU 40 SEE REMARK 999

SEQRES 1 A 271 TYR LYS MET PRO ARG LEU HIS THR ALA ALA GLU VAL LEU SEQRES 2 A 271 ASP ASN ALA ARG LYS ILE ALA ASP MET ILE VAL GLY MET SEQRES 3 A 271 LYS GLN GLY LEU PRO GLY MET ASP LEU VAL VAL PHE PRO SEQRES 4 A 271 GLU TYR SER LEU GLN GLY ILE MET TYR ASP PRO ALA GLU SEQRES 5 A 271 MET MET GLU THR ALA VAL ALA ILE PRO GLY GLU GLU THR SEQRES 6 A 271 GLU ILE PHE SER ARG ALA CYS ARG LYS ALA ASN VAL TRP SEQRES 7 A 271 GLY VAL PHE SER LEU THR GLY GLU ARG HIS GLU GLU HIS SEQRES 8 A 271 PRO ARG LYS ALA PRO TYR ASN THR LEU VAL LEU ILE ASP SEQRES 9 A 271 ASN ASN GLY GLU ILE VAL GLN LYS TYR ARG LYS ILE ILE SEQRES 10 A 271 PRO TRP CYS PRO ILE GLU GLY TRP TYR PRO GLY GLY GLN SEQRES 11 A 271 THR TYR VAL SER GLU GLY PRO LYS GLY MET LYS ILE SER SEQRES 12 A 271 LEU ILE ILE CYS ASP ASP GLY ASN TYR PRO GLU ILE TRP SEQRES 13 A 271 ARG ASP CYS ALA MET LYS GLY ALA GLU LEU ILE VAL ARG SEQRES 14 A 271 CYS GLN GLY TYR MET TYR PRO ALA LYS ASP GLN GLN VAL SEQRES 15 A 271 MET MET ALA LYS ALA MET ALA TRP ALA ASN ASN CYS TYR SEQRES 16 A 271 VAL ALA VAL ALA ASN ALA ALA GLY PHE ASP GLY VAL TYR SEQRES 17 A 271 SER TYR PHE GLY HIS SER ALA ILE ILE GLY PHE ASP GLY SEQRES 18 A 271 ARG THR LEU GLY GLU CYS GLY GLU GLU GLU MET GLY ILE SEQRES 19 A 271 GLN TYR ALA GLN LEU SER LEU SER GLN ILE ARG ASP ALA SEQRES 20 A 271 ARG ALA ASN ASP GLN SER GLN ASN HIS LEU PHE LYS ILE SEQRES 21 A 271 LEU HIS ARG GLY TYR SER GLY LEU GLN ALA SER

HELIX 1 1 GLU A 30 GLY A 48 1 19 HELIX 2 2 ASP A 68 THR A 75 1 8 HELIX 3 3 GLY A 81 ASN A 95 1 15 HELIX 4 4 ILE A 165 ASN A 170 5 6 HELIX 5 5 PRO A 172 LYS A 181 1 10 HELIX 6 6 PRO A 195 ASN A 212 1 18 HELIX 7 7 SER A 259 ASP A 270 1 12 HELIX 8 8 GLN A 271 LEU A 276 1 6

SHEET 1 A 4 LEU A 54 PHE A 57 0 SHEET 2 A 4 TRP A 97 ARG A 106 1 O VAL A 99 N VAL A 55 SHEET 3 A 4 TYR A 116 ILE A 122 -1 O TYR A 116 N ARG A 106 SHEET 4 A 4 ILE A 128 ARG A 133 -1 O VAL A 129 N LEU A 121 SHEET 1 B 5 ILE A 161 ILE A 164 0 SHEET 2 B 5 LEU A 185 ARG A 188 1 O LEU A 185 N SER A 162 SHEET 3 B 5 TYR A 214 ALA A 216 1 O ALA A 216 N ILE A 186 SHEET 4 B 5 ALA A 234 ILE A 236 -1 O ILE A 236 N VAL A 215 SHEET 5 B 5 THR A 242 GLU A 245 -1 O GLY A 244 N ILE A 235 SHEET 1 C 2 ALA A 221 PHE A 223 0 SHEET 2 C 2 SER A 228 PHE A 230 -1 O TYR A 229 N GLY A 222

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000